Related Experiment Video
Updated: Jul 18, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
WWP2 deletion aggravates acute kidney injury by targeting CDC20/autophagy axis
Ran You1, Yanwei Li2, Yuteng Jiang3
1Nanjing Key Laboratory of Pediatrics, Children's Hospital of Nanjing Medical University, Nanjing, China; Jiangsu Key Laboratory of Pediatrics, Nanjing Medical University, Nanjing, China; Department of Nephrology, Children's Hospital of Nanjing Medical University, Nanjing, China.
Introduction:
Acute kidney injury (AKI) is associated with high morbidity and mortality rates. The molecular mechanisms underlying AKI are currently being extensively investigated. WWP2 is an E3 ligase that regulates cell proliferation and differentiation. Whether WWP2 plays a regulatory role in AKI remains to be elucidated.
Objectives:
We aimed to investigate the implication of WWP2 in AKI and its underlying mechanism in the present study.
Methods:
We utilized renal tissues from patients with AKI and established AKI models in global or tubule-specific knockout (cKO) mice strains to study WWP2's implication in AKI. We also systemically analyzed ubiquitylation omics and proteomics to decipher the underlying mechanism.
Results:
In the present study, we found that WWP2 expression significantly increased in the tubules of kidneys with AKI. Global or tubule-specific knockout of WWP2 significantly aggravated renal dysfunction and tubular injury in AKI kidneys, whereas WWP2 overexpression significantly protected tubular epithelial cells against cisplatin. WWP2 deficiency profoundly affected autophagy in AKI kidneys. Further analysis with ubiquitylation omics, quantitative proteomics and experimental validation suggested that WWP2 mediated poly-ubiquitylation of CDC20, a negative regulator of autophagy. CDC20 was significantly decreased in AKI kidneys, and selective inhibiting CDC20 with apcin profoundly alleviated renal dysfunction and tubular injury in the cisplatin model with or without WWP2 cKO, indicating that CDC20 may serve as a downstream target of WWP2 in AKI. Inhibiting autophagy with 3-methyladenine blocked apcin's protection against cisplatin-induced renal tubular cell injury. Activating autophagy by rapamycin significantly protected against cisplatin-induced AKI in WWP2 cKO mice, whereas inhibiting autophagy by 3-methyladenine further aggravated apoptosis in cisplatin-exposed WWP2 KO cells.
Conclusion:
Taken together, our data indicated that the WWP2/CDC20/autophagy may be an essential intrinsic protective mechanism against AKI. Further activating WWP2 or inhibiting CDC20 may be novel therapeutic strategies for AKI.
Insights
WWP2, an E3 ligase, protects against acute kidney injury (AKI) by regulating CDC20 and autophagy. Activating WWP2 or inhibiting CDC20 may offer new therapeutic strategies for AKI patients.
Area of Science:
- Nephrology
- Molecular Biology
- Cellular Biology
Background:
- Acute kidney injury (AKI) presents significant morbidity and mortality.
- The molecular underpinnings of AKI are under active investigation.
- WWP2, an E3 ligase, is known to regulate cell proliferation and differentiation, but its role in AKI is unclear.
Purpose of the Study:
- To investigate the role of WWP2 in AKI.
- To elucidate the underlying molecular mechanisms of WWP2 in AKI.
Main Methods:
- Utilized human AKI renal tissues and mouse models (global/tubule-specific WWP2 knockout).
- Conducted ubiquitylation omics and quantitative proteomics.
- Performed experimental validation of identified targets and pathways.
Main Results:
- WWP2 expression is upregulated in AKI kidneys.
- WWP2 deficiency exacerbates AKI, while overexpression is protective.
- WWP2 regulates autophagy via poly-ubiquitylation of CDC20, a negative autophagy regulator.
- Targeting WWP2/CDC20/autophagy pathway demonstrates therapeutic potential in AKI models.
Conclusions:
- The WWP2/CDC20/autophagy axis represents a critical intrinsic protective mechanism against AKI.
- Modulating WWP2 or CDC20 could offer novel therapeutic avenues for AKI.
More Related Videos
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Acute Pancreatitis II: Pathophysiology

